- Home
- ACAD vs LMND Comparison
ACAD vs LMND Comparison
Compare ACAD & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- LMND
- Stock Information
- Founded
- ACAD 1993
- LMND 2015
- Country
- ACAD United States
- LMND United States
- Employees
- ACAD N/A
- LMND N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- LMND Property-Casualty Insurers
- Sector
- ACAD Health Care
- LMND Finance
- Exchange
- ACAD Nasdaq
- LMND Nasdaq
- Market Cap
- ACAD 2.5B
- LMND 2.1B
- IPO Year
- ACAD 2004
- LMND 2020
- Fundamental
- Price
- ACAD $21.57
- LMND $33.53
- Analyst Decision
- ACAD Buy
- LMND Hold
- Analyst Count
- ACAD 14
- LMND 9
- Target Price
- ACAD $27.08
- LMND $34.56
- AVG Volume (30 Days)
- ACAD 3.0M
- LMND 2.0M
- Earning Date
- ACAD 05-07-2025
- LMND 05-06-2025
- Dividend Yield
- ACAD N/A
- LMND N/A
- EPS Growth
- ACAD N/A
- LMND N/A
- EPS
- ACAD 1.37
- LMND N/A
- Revenue
- ACAD $996,283,000.00
- LMND $558,600,000.00
- Revenue This Year
- ACAD $13.49
- LMND $29.18
- Revenue Next Year
- ACAD $10.58
- LMND $31.15
- P/E Ratio
- ACAD $15.76
- LMND N/A
- Revenue Growth
- ACAD 22.42
- LMND 23.12
- 52 Week Low
- ACAD $13.40
- LMND $14.03
- 52 Week High
- ACAD $25.23
- LMND $53.85
- Technical
- Relative Strength Index (RSI)
- ACAD 68.70
- LMND 59.64
- Support Level
- ACAD $21.95
- LMND $31.60
- Resistance Level
- ACAD $22.62
- LMND $34.20
- Average True Range (ATR)
- ACAD 1.21
- LMND 1.79
- MACD
- ACAD 0.23
- LMND 0.19
- Stochastic Oscillator
- ACAD 56.27
- LMND 87.80
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.